The cause of atherosclerosis: Secretory dysfunction in vascular endothelial cells and proliferation of smooth muscle cells

Chinese Pharmacological Bulletin

Volumn 26, Issue 2, 2010, Pages 155-158

  Li, Lei ^a   Dai, Min ^a  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Atherosclerosis; Cytokines; Growth factor; Smooth muscle cell; Uproliferation; Vascular endothelial cell; Vascular substances

Indexed keywords

CYTOKINE; GROWTH FACTOR; VASOACTIVE AGENT;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL OCCLUSION; BLOOD VESSEL WALL; CELL DAMAGE; CELL INTERACTION; CELL PROLIFERATION; CELL SECRETION; DISEASE COURSE; ENDOTHELIUM CELL; MUSCLE SPASM; PATHOLOGY; SECRETION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 77951799634     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Libby P, Ridker P M, Maseri A. Inflammation and atherosclerosis [J]. Circulation, 2002, 105(9):1135-1143
2. Qin C C, Liu Z H. In atherogenesis, the apoptosis of endothehal cell itself could directly induce over-proliferation of smooth muscle cells [J]. Med Hypotheses, 2007, 68(2):275-277
3. Santos S C, Miguel C, Domingues I, et al. VEGF and VEGF-2 (KDR) internalization is required for endothehal recovery during wound healing [J]. Exp Cell Res, 2001, 313(8):1561-1574
4. Alessandra C, Valeria B, Bruto R, et al. Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells [J]. J Surgical Res, 2003, 109(1):16-23.
5. Wysocki S J, Zheng M H, Smith A, Norman P E. Vascular endothelial growth factor(VEGF) expression during arterial repair in the pig [J]. Eur J Vasc Endovasc Surg, 1998, 15(3):225-230 (Pubitemid 28163672)
6. 1, expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration [J]. Microvascular Res, 2009, 77(2):134-142
7. Maedas S, Dean D D, Gomez R, et al. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3) [J]. Calcif Tissue Int, 2002, 70(1):54-65. (Pubitemid 36934737)
8. Bobik A. Transforming growth factor-betas and vascular disorders [J]. Arterioscler Thromb Vasc Biol, 2006, 26(8):1712-1720 (Pubitemid 44305323)
9. 1, in cardiac fibroblasts and myofibroblasts [J]. J Mol Cell Cardiol, 2004, 29(1):1947-1958
10. 1, induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK [J]. J Biol Chem, 2005, 280(35):31172-31181 (Pubitemid 41291854)
11. Grainger D J. Transforming growth factor β and atherosclerosis: so far, so good for the protective cytokine hypothesis [J]. Arterioscler Thromb Vasc Biol, 2004, 24(3):399-404.
12. Sakao S, Taraseviciene-Stewart L, Wood K, et al. Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth [J]. Am J Physiol Lung Cell Mol Physiol, 2006, 291(3):362-368 (Pubitemid 44343711)
13. Tanaga K, Bujo H, Zhu Y, et al. LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors [J]. Arterioscler Thromb Vasc Biol, 2004, 24(8):1422-1428 (Pubitemid 39050435)
14. Perros F, Montani D, Dorfmüller P, et al. Plateletderived growth factor expression and function in idiopathic pulmonary arterial hypertension [J]. Am J Respir Crit Care Med, 2008, 178(1):81-88 (Pubitemid 351919196)
15. Francy J M, Nag A, Concroy E J, et al. Sphingosine kinase 1 expression is regulated by signaling through PI3K, AKT2, and mTOR in human coronary artery smooth muscle cells [J]. Biochim Biophys Acta, 2007, 1769(4):253-265
16. Nakata S, Fujita N, Kitagawa Y, et al. Regulation of plateletderived growth factor receptor activation by afadin through SHP-2: implications for cellular [J]. J Biol Chem, 2007, 282(52):37815-37825
17. Sandilands E, Cans C, Fincham V J, et al. RhoB and actin polymerization coordinate Src activation with endosomemediated delivery to the membrane [J]. Dev Cell, 2004, 7(6):855-869 (Pubitemid 39654730)
18. Li Y J, Yang Q, Weng X G. The research development of inflammatory signal pathway of atherosclerosis [J]. Chin Pharmacol Bull, 2009, 25(7):857-860
19. Raymond M A, Désormeaux A, Laplante P, et al. Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on vascular smooth muscle cells [J]. FASEB J, 2004, 18(6):705-723
20. Zhang B, Liu Z H, Ouyang P, et al. Effect of tumor necrosis factor-α on proliferation proliferation of in vitro cultured rat VSMC and expression of syndecan-4 protein [J]. Chin J Neuromed, 2007, 6(7):657-659
21. Koo B K, Jung Y S, Shin J, et al. Structural basis of syndecan-4 phosphorylation as a molecular switch to regulate signaling [J]. J Mol Biol, 2006, 355(4):651-663 (Pubitemid 41817626)
22. Petkova S B, Huang H, Factor S M, et al. The role of endothelin in the pathogenesis of chagas's disease [J]. Int J Parasitol, 2001, 31(5-6):499-511. (Pubitemid 32382048)
23. Wildgruber M, Weiss W, Berger H, et al. Transforming growth factor beta, tumor necrosis factor alpha and basic fibroblast growth factor with restenosis after transluminal angioplasty [J]. Eur J Vasc Endovasc Surg, 2001, 34(1):35-43.
24. Fang Y Q, Huang L, Zhao X H, et al. Effects of HUVEC over-expressing EL on bionomics of SMC [J]. Chongqing Med, 2009, 38(4):429-31.